GRI Bio, Inc. (GRI)
1.93
+0.09
(+4.89%)
USD |
NASDAQ |
Sep 18, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 20:00
GRI Bio Price to Book Value : 0.4104 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 0.4104 |
| September 17, 2026 | 0.3913 |
| September 16, 2026 | 0.3849 |
| September 15, 2026 | 0.387 |
| September 14, 2026 | 0.4019 |
| September 11, 2026 | 0.404 |
| September 10, 2026 | 0.4126 |
| September 09, 2026 | 0.3828 |
| September 08, 2026 | 0.4253 |
| September 04, 2026 | 0.6124 |
| September 03, 2026 | 0.487 |
| September 02, 2026 | 0.4253 |
| September 01, 2026 | 0.4062 |
| August 31, 2026 | 0.4083 |
| August 28, 2026 | 0.4083 |
| August 27, 2026 | 0.4402 |
| August 26, 2026 | 0.4062 |
| August 25, 2026 | 0.4168 |
| August 24, 2026 | 0.3807 |
| August 21, 2026 | 0.3509 |
| August 20, 2026 | 0.3551 |
| August 19, 2026 | 0.3679 |
| August 18, 2026 | 0.3636 |
| August 17, 2026 | 0.3679 |
| August 14, 2026 | 0.3551 |
| Date | Value |
|---|---|
| August 13, 2026 | 0.3764 |
| August 12, 2026 | 0.4147 |
| August 11, 2026 | 0.4678 |
| August 10, 2026 | 0.3615 |
| August 07, 2026 | 0.3126 |
| August 06, 2026 | 0.3296 |
| August 05, 2026 | 0.3254 |
| August 04, 2026 | 0.3381 |
| August 03, 2026 | 0.3062 |
| July 31, 2026 | 0.2935 |
| July 30, 2026 | 0.2998 |
| July 29, 2026 | 0.3126 |
| July 28, 2026 | 0.3041 |
| July 27, 2026 | 0.2977 |
| July 24, 2026 | 0.3084 |
| July 23, 2026 | 0.319 |
| July 22, 2026 | 0.3147 |
| July 21, 2026 | 0.3211 |
| July 20, 2026 | 0.3126 |
| July 17, 2026 | 0.319 |
| July 16, 2026 | 0.3275 |
| July 15, 2026 | 0.3445 |
| July 14, 2026 | 0.3339 |
| July 13, 2026 | 0.3445 |
| July 10, 2026 | 0.37 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.595 |
| Alnylam Pharmaceuticals, Inc. | 23.66 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
| Vericel Corp. | 5.534 |
Price to Book Value Related Metrics
| Price | 1.93 |
| Earnings Yield | -2.27K% |
| Market Cap | 4.219M |